JAK-STAT and G-protein-coupled receptor signaling pathways are frequently altered in epitheliotropic intestinal T-cell lymphoma.

PubWeight™: 0.89‹?›

🔗 View Article (PMID 26854024)

Published in Leukemia on February 08, 2016

Authors

M-L Nairismägi1, J Tan1,2,3, J Q Lim1, S Nagarajan2,3, C C Y Ng2,3, V Rajasegaran2,3, D Huang2,3, W K Lim1, Y Laurensia1, G C Wijaya2,3, Z M Li2,3, I Cutcutache3,4, W L Pang1, S Thangaraju2,3, J Ha1, L P Khoo1, S T Chin1, S Dey5, G Poore6, L H C Tan7, H K M Koh8, K Sabai8, H-L Rao9, K L Chuah10, Y-H Ho10, S-B Ng5,11,12, S-S Chuang13,14, F Zhang15, Y-H Liu15, T Pongpruttipan16, Y H Ko17, P-L Cheah18, N Karim19, W-J Chng5,20, T Tang21, M Tao21, K Tay21, M Farid21, R Quek21, S G Rozen3,4, P Tan3,5,22, B T Teh2,3,5,23, S T Lim1,21,24, S-Y Tan7,11,12,15,18,23, C K Ong1

Author Affiliations

1: Lymphoma Genomic Translational Research Laboratory, Division of Medical Oncology, National Cancer Centre Singapore, Singapore, Singapore.
2: Laboratory of Cancer Epigenome, Division of Medical Sciences, National Cancer Centre Singapore, Singapore, Singapore.
3: Program in Cancer and Stem Cell Biology, Duke-NUS Medical School, Singapore, Singapore.
4: Centre for Computational Biology, Duke-NUS Medical School, Singapore, Singapore.
5: Cancer Science Institute of Singapore, National University of Singapore, Singapore, Singapore.
6: Department of Biomedical Engineering, Duke University, Durham, NC, USA.
7: Department of Pathology, Singapore General Hospital, Singapore, Singapore.
8: Advanced Molecular Pathology Laboratory, Singapore Health Services, Singapore, Singapore.
9: Department of Pathology, Sun Yat-sen University Cancer Center, Guangzhou, China.
10: Department of Pathology, Tan Tock Seng Hospital, Singapore, Singapore.
11: Department of Pathology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
12: Department of Pathology, National University Hospital, National University Health System, Singapore, Singapore.
13: Department of Pathology, Chi Mei Medical Center, Tainan, Taiwan.
14: Department of Pathology, Taipei Medical University and National Taiwan University, Taipei, Taiwan.
15: Department of Pathology, Guangdong General Hospital, Guangzhou, China.
16: Department of Pathology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.
17: Department of Pathology, Samsung Medical Centre, Sungkyunkwan University School of Medicine, Seoul, South Korea.
18: Department of Pathology, University of Malaya, Kuala Lumpur, Malaysia.
19: Department of Pathology, Hospital Raja Permaisuri Bainun, Ipoh, Malaysia.
20: Department of Haematology-Oncology, National University Hospital, National University Health System, Singapore, Singapore.
21: Division of Medical Oncology, National Cancer Centre Singapore, Singapore, Singapore.
22: Genome Institute of Singapore, A*STAR, Singapore, Singapore.
23: Institute of Molecular and Cell Biology, A*STAR, Singapore, Singapore.
24: Office of Education, Duke-NUS Medical School, Singapore, Singapore.

Articles cited by this

Gene Expression Omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Res (2002) 76.95

A framework for variation discovery and genotyping using next-generation DNA sequencing data. Nat Genet (2011) 59.36

Integrative genomics viewer. Nat Biotechnol (2011) 42.83

Patterns of somatic mutation in human cancer genomes. Nature (2007) 38.41

Integrative Genomics Viewer (IGV): high-performance genomics data visualization and exploration. Brief Bioinform (2012) 23.58

A gain-of-function mutation of JAK2 in myeloproliferative disorders. N Engl J Med (2005) 21.48

Mutational heterogeneity in cancer and the search for new cancer-associated genes. Nature (2013) 20.16

Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples. Nat Biotechnol (2013) 16.13

Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma. Nature (2011) 9.71

Molecular signatures database (MSigDB) 3.0. Bioinformatics (2011) 8.08

Efficient and rapid induction of a chronic myelogenous leukemia-like myeloproliferative disease in mice receiving P210 bcr/abl-transduced bone marrow. Blood (1998) 6.81

Inactivating mutations of acetyltransferase genes in B-cell lymphoma. Nature (2011) 5.20

Strelka: accurate somatic small-variant calling from sequenced tumor-normal sample pairs. Bioinformatics (2012) 5.04

Two G protein oncogenes in human endocrine tumors. Science (1990) 4.46

CREBBP mutations in relapsed acute lymphoblastic leukaemia. Nature (2011) 3.72

Targeting dual-specificity phosphatases: manipulating MAP kinase signalling and immune responses. Nat Rev Drug Discov (2007) 2.97

Enteropathy-associated T-cell lymphoma: clinical and histological findings from the international peripheral T-cell lymphoma project. Blood (2011) 2.25

PI3K in cancer: divergent roles of isoforms, modes of activation and therapeutic targeting. Nat Rev Cancer (2015) 2.10

The emerging mutational landscape of G proteins and G-protein-coupled receptors in cancer. Nat Rev Cancer (2013) 2.05

MAP kinase is constitutively activated in gip2 and src transformed rat 1a fibroblasts. J Biol Chem (1992) 1.91

SciClone: inferring clonal architecture and tracking the spatial and temporal patterns of tumor evolution. PLoS Comput Biol (2014) 1.88

Hierarchy in somatic mutations arising during genomic evolution and progression of follicular lymphoma. Blood (2013) 1.86

Human MAIT and CD8αα cells develop from a pool of type-17 precommitted CD8+ T cells. Blood (2011) 1.83

Mitogenic signaling via G protein-coupled receptors. Endocr Rev (1996) 1.81

Integration of gene mutations in risk prognostication for patients receiving first-line immunochemotherapy for follicular lymphoma: a retrospective analysis of a prospective clinical trial and validation in a population-based registry. Lancet Oncol (2015) 1.74

CoMEt: a statistical approach to identify combinations of mutually exclusive alterations in cancer. Genome Biol (2015) 1.64

Allelic and haplotypic diversity of HLA-A, -B, -C, -DRB1, and -DQB1 genes in the Korean population. Tissue Antigens (2005) 1.61

Allele frequencies and haplotypic associations defined by allelic DNA typing at HLA class I and class II loci in the Japanese population. Tissue Antigens (2000) 1.60

Type II enteropathy-associated T-cell lymphoma: a distinct aggressive lymphoma with frequent γδ T-cell receptor expression. Am J Surg Pathol (2011) 1.52

Convergent mutations and kinase fusions lead to oncogenic STAT3 activation in anaplastic large cell lymphoma. Cancer Cell (2015) 1.49

Exome-wide Sequencing Shows Low Mutation Rates and Identifies Novel Mutated Genes in Seminomas. Eur Urol (2015) 1.48

Activating mutations of STAT5B and STAT3 in lymphomas derived from γδ-T or NK cells. Nat Commun (2015) 1.43

A mutant alpha subunit of Gi2 induces neoplastic transformation of Rat-1 cells. Proc Natl Acad Sci U S A (1991) 1.40

Distribution of HLA gene and haplotype frequencies in Taiwan: a comparative study among Min-nan, Hakka, Aborigines and Mainland Chinese. Tissue Antigens (1999) 1.26

Stat5 promotes metastatic behavior of human prostate cancer cells in vitro and in vivo. Endocr Relat Cancer (2010) 1.16

Whole-genome sequencing reveals oncogenic mutations in mycosis fungoides. Blood (2015) 0.99

Enteropathy-associated T-cell lymphoma--a clinicopathologic and array comparative genomic hybridization study. Hum Pathol (2010) 0.96

Genotype frequency and F ST analysis of polymorphisms in immunoregulatory genes in Chinese and Caucasian populations. Immunogenetics (2007) 0.96

Primary CD56 positive lymphomas of the gastrointestinal tract. Cancer (2001) 0.93

Primary intestinal T-cell and NK-cell lymphomas: a clinicopathological and molecular study from China focused on type II enteropathy-associated T-cell lymphoma and primary intestinal NK-cell lymphoma. Mod Pathol (2011) 0.93

The histone deacetylase inhibitors vorinostat and romidepsin downmodulate IL-10 expression in cutaneous T-cell lymphoma cells. Br J Pharmacol (2011) 0.89

Type II EATL (epitheliotropic intestinal T-cell lymphoma): a neoplasm of intra-epithelial T-cells with predominant CD8αα phenotype. Leukemia (2013) 0.89

STAT3 knockdown by siRNA induces apoptosis in human cutaneous T-cell lymphoma line Hut78 via downregulation of Bcl-xL. Cell Mol Biol Lett (2010) 0.88

Significance of Thr182 in the nucleotide-exchange and GTP-hydrolysis reactions of the alpha subunit of GTP-binding protein Gi2. J Biochem (1995) 0.84

Nuclear expression of MATK is a novel marker of type II enteropathy-associated T-cell lymphoma. Leukemia (2011) 0.83

An unusual enteropathy-associated T-cell lymphoma with MYC translocation arising in a Japanese patient: a case report. World J Gastroenterol (2012) 0.82

Exploring the IL-21-STAT3 axis as therapeutic target for Sézary syndrome. J Invest Dermatol (2014) 0.82

Recent advances in intestinal lymphomas. Histopathology (2015) 0.81

Intestinal γδ T-cell lymphomas are most frequently of type II enteropathy-associated T-cell type. Hum Pathol (2013) 0.81

The phenotype of intraepithelial lymphocytes in Taiwanese enteropathy-associated T-cell lymphoma is distinct from that of the West. Histopathology (2008) 0.78

Association of HLA type and Mooren's Ulcer in Chinese in Taiwan. Br J Ophthalmol (2003) 0.76

Identification of a homozygous JAK3 V674A mutation caused by acquired uniparental disomy in a relapsed early T-cell precursor ALL patient. Int J Hematol (2014) 0.76